Quantity and Activation of Myofiber-Associated Satellite Cells in a Mouse Model of Amyotrophic Lateral Sclerosis

Stem Cell Reviews and Reports

Volumn 8, Issue 1, 2012, Pages 279-287

  Manzano, Raquel ^a   Toivonen, Janne M ^a   Calvo, Ana Cristina ^a   Oliván, Sara ^a   Zaragoza, Pilar ^a   Muñoz, Maria Jesús ^a   Montarras, Didier ^b   Osta, Rosario ^a  

^a UNIVERSITY OF ZARAGOZA   (Spain)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MYOD PROTEIN; MYOD1 MYOGENIC DIFFERENTIATION PROTEIN; PAX7 PROTEIN, MOUSE; SOD1 G93A PROTEIN; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR PAX7;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL; ARTICLE; CELL COUNT; CELL PROLIFERATION; DISEASE MODEL; ENZYMOLOGY; FAST MUSCLE FIBER; GENETICS; MALE; METABOLISM; MOUSE; PATHOLOGY; PHYSIOLOGY; SKELETAL MUSCLE SATELLITE CELL; SLOW MUSCLE FIBER; TRANSGENIC MOUSE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CELL COUNT; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; MALE; MICE; MICE, TRANSGENIC; MUSCLE FIBERS, FAST-TWITCH; MUSCLE FIBERS, SLOW-TWITCH; MYOD PROTEIN; PAX7 TRANSCRIPTION FACTOR; SATELLITE CELLS, SKELETAL MUSCLE; SUPEROXIDE DISMUTASE;

EID: 84857659012     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-011-9268-0     Document Type: Article

References (67)

1. Gros-Louis, F., Gaspar, C., & Rouleau, G. A. (2006). Genetics of familial and sporadic amyotrophic lateral sclerosis. Biochimica et Biophysica Acta, 1762(11-12), 956-972.
2. Julien, J. P., & Kriz, J. (2006). Transgenic mouse models of amyotrophic lateral sclerosis. Biochimica et Biophysica Acta, 1762(11-12), 1013-1024.
3. Kato, S. (2008). Amyotrophic lateral sclerosis models and human neuropathology: similarities and differences. Acta Neuropathologica, 115(1), 97-114.
4. Shibata, N. (2001). Transgenic mouse model for familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation. Neuropathology, 21(1), 82-92.
5. Gurney, M. E. (1994). Transgenic-mouse model of amyotrophic lateral sclerosis. The New England Journal of Medicine, 331(25), 1721-1722.
6. Gurney, M. E. (1997). Transgenic animal models of familial amyotrophic lateral sclerosis. Journal of Neurology, 244(Suppl 2), S15-S20.
7. Miana-Mena, F. J., Munoz, M. J., Yague, G., et al. (2005). Optimal methods to characterize the G93A mouse model of ALS. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 6(1), 55-62.
8. Lino, M. M., Schneider, C., & Caroni, P. (2002). Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease. The Journal of Neuroscience, 22(12), 4825-4832.
9. Pramatarova, A., Laganiere, J., Roussel, J., Brisebois, K., & Rouleau, G. A. (2001). Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment. The Journal of Neuroscience, 21(10), 3369-3374.
10. Gong, Y. H., Parsadanian, A. S., Andreeva, A., Snider, W. D., & Elliott, J. L. (2000). Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration. The Journal of Neuroscience, 20(2), 660-665.
11. Beers, D. R., Henkel, J. S., Xiao, Q., et al. (2006). Wild-type microglia extend survival in PU. 1 knockout mice with familial amyotrophic lateral sclerosis. Proceedings of the National Academy of Sciences of the United States of America, 103(43), 16021-16026.
12. Nagai, M., Re, D. B., Nagata, T., et al. (2007). Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nature Neuroscience, 10(5), 615-622.
13. Yamanaka, K., Chun, S. J., Boillee, S., et al. (2008). Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nature Neuroscience, 11(3), 251-253.
14. Boillee, S., Vande Velde, C., & Cleveland, D. W. (2006). ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron, 52(1), 39-59.
15. Martin, L. J., & Liu, Z. (2007). Adult olfactory bulb neural precursor cell grafts provide temporary protection from motor neuron degeneration, improve motor function, and extend survival in amyotrophic lateral sclerosis mice. Journal of Neuropathology and Experimental Neurology, 66(11), 1002-1018.
16. Clement, A. M., Nguyen, M. D., Roberts, E. A., et al. (2003). Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science, 302(5642), 113-117.
17. Aguirre, T., van Den Bosch, L., Goetschalckx, K., et al. (1998). Increased sensitivity of fibroblasts from amyotrophic lateral sclerosis patients to oxidative stress. Annals of Neurology, 43(4), 452-457.
18. McEachern, G., Kassovska-Bratinova, S., Raha, S., et al. (2000). Manganese superoxide dismutase levels are elevated in a proportion of amyotrophic lateral sclerosis patient cell lines. Biochemical and Biophysical Research Communications, 273(1), 359-363.
19. Cova, E., Cereda, C., Galli, A., et al. (2006). Modified expression of Bcl-2 and SOD1 proteins in lymphocytes from sporadic ALS patients. Neuroscience Letters, 399(3), 186-190.
20. Dupuis, L., Gonzalez de Aguilar, J. L., Echaniz-Laguna, A., & Loeffler, J. P. (2006). Mitochondrial dysfunction in amyotrophic lateral sclerosis also affects skeletal muscle. Muscle & Nerve, 34(2), 253-254.
21. Wiedemann, F. R., Winkler, K., Kuznetsov, A. V., et al. (1998). Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis. Journal of the Neurological Sciences, 156(1), 65-72.
22. Brooks, K. J., Hill, M. D., Hockings, P. D., & Reid, D. G. (2004). MRI detects early hindlimb muscle atrophy in Gly93Ala superoxide dismutase-1 (G93A SOD1) transgenic mice, an animal model of familial amyotrophic lateral sclerosis. NMR in Biomedicine, 17(1), 28-32.
23. Fischer, L. R., Culver, D. G., Tennant, P., et al. (2004). Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Experimental Neurology, 185(2), 232-240.
24. Chiu, A. Y., Zhai, P., Dal Canto, M. C., et al. (1995). Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis. Molecular and Cellular Neurosciences, 6(4), 349-362.
25. Dupuis, L., & Loeffler, J. P. (2009). Neuromuscular junction destruction during amyotrophic lateral sclerosis: insights from transgenic models. Current Opinion in Pharmacology, 9(3), 341-346.
26. Krasnianski, A., Deschauer, M., Neudecker, S., et al. (2005). Mitochondrial changes in skeletal muscle in amyotrophic lateral sclerosis and other neurogenic atrophies. Brain, 128(Pt 8), 1870-1876.
27. Vielhaber, S., Winkler, K., Kirches, E., et al. (1999). Visualization of defective mitochondrial function in skeletal muscle fibers of patients with sporadic amyotrophic lateral sclerosis. Journal of the Neurological Sciences, 169(1-2), 133-139.
28. Comi, G. P., Bordoni, A., Salani, S., et al. (1998). Cytochrome c oxidase subunit I microdeletion in a patient with motor neuron disease. Annals of Neurology, 43(1), 110-116.
29. Echaniz-Laguna, A., Zoll, J., Ponsot, E., et al. (2006). Muscular mitochondrial function in amyotrophic lateral sclerosis is progressively altered as the disease develops: a temporal study in man. Experimental Neurology, 198(1), 25-30.
30. Corti, S., Donadoni, C., Ronchi, D., et al. (2009). Amyotrophic lateral sclerosis linked to a novel SOD1 mutation with muscle mitochondrial dysfunction. Journal of the Neurological Sciences, 276(1-2), 170-174.
31. Vielhaber, S., Kornblum, C., Heinze, H. J., Elger, C. E., & Kunz, W. S. (2005). Mitochondrial changes in skeletal muscle in amyotrophic lateral sclerosis and other neurogenic atrophies-a comment. Brain, 128(Pt 12), E38.
32. Derave, W., van Den Bosch, L., Lemmens, G., Eijnde, B. O., Robberecht, W., & Hespel, P. (2003). Skeletal muscle properties in a transgenic mouse model for amyotrophic lateral sclerosis: effects of creatine treatment. Neurobiology of Disease, 13(3), 264-272.
33. Dupuis, L., Oudart, H., Rene, F., Gonzalez de Aguilar, J. L., & Loeffler, J. P. (2004). Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proceedings of the National Academy of Sciences of the United States of America, 101(30), 11159-11164.
34. Mahoney, D. J., Kaczor, J. J., Bourgeois, J., Yasuda, N., & Tarnopolsky, M. A. (2006). Oxidative stress and antioxidant enzyme upregulation in SOD1-G93A mouse skeletal muscle. Muscle & Nerve, 33(6), 809-816.
35. Dobrowolny, G., Aucello, M., Rizzuto, E., et al. (2008). Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. Cell Metabolism, 8(5), 425-436.
36. Wong, M., & Martin, L. J. Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice. Human Molecular Genetics, 19(11), 2284-2302.
37. Dobrowolny, G., Aucello, M., Molinaro, M., & Musaro, A. (2008). Local expression of mIgf-1 modulates ubiquitin, caspase and CDK5 expression in skeletal muscle of an ALS mouse model. Neurological Research, 30(2), 131-136.
38. Dobrowolny, G., Giacinti, C., Pelosi, L., et al. (2005). Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model. The Journal of Cell Biology, 168(2), 193-199.
39. Jokic, N., Gonzalez de Aguilar, J. L., Dimou, L., et al. (2006). The neurite outgrowth inhibitor Nogo-A promotes denervation in an amyotrophic lateral sclerosis model. EMBO Reports, 7(11), 1162-1167.
40. Kaspar, B. K., Llado, J., Sherkat, N., Rothstein, J. D., & Gage, F. H. (2003). Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science, 301(5634), 839-842.
41. Ates, K., Yang, S. Y., Orrell, R. W., et al. (2007). The IGF-I splice variant MGF increases progenitor cells in ALS, dystrophic, and normal muscle. FEBS Letters, 581(14), 2727-2732.
42. Musaro, A., Giacinti, C., Borsellino, G., et al. (2004). Stem cell-mediated muscle regeneration is enhanced by local isoform of insulin-like growth factor 1. Proceedings of the National Academy of Sciences of the United States of America, 101(5), 1206-1210.
43. Seale, P., & Rudnicki, M. A. (2000). A new look at the origin, function, and "stem-cell" status of muscle satellite cells. Developmental Biology, 218(2), 115-124.
44. Buckingham, M. (2007). Skeletal muscle progenitor cells and the role of Pax genes. Comptes Rendus Biologies, 330(6-7), 530-533.
45. Zammit, P. S., Golding, J. P., Nagata, Y., Hudon, V., Partridge, T. A., & Beauchamp, J. R. (2004). Muscle satellite cells adopt divergent fates: a mechanism for self-renewal? The Journal of Cell Biology, 166(3), 347-357.
46. Collins, C. A., Olsen, I., Zammit, P. S., et al. (2005). Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell, 122(2), 289-301.
47. Seale, P., Sabourin, L. A., Girgis-Gabardo, A., Mansouri, A., Gruss, P., & Rudnicki, M. A. (2000). Pax7 is required for the specification of myogenic satellite cells. Cell, 102(6), 777-786.
48. Shefer, G., & Yablonka-Reuveni, Z. (2005). Isolation and culture of skeletal muscle myofibers as a means to analyze satellite cells. Methods in Molecular Biology, 290, 281-304.
49. Cooper, R. N., Tajbakhsh, S., Mouly, V., Cossu, G., Buckingham, M., & Butler-Browne, G. S. (1999). In vivo satellite cell activation via Myf5 and MyoD in regenerating mouse skeletal muscle. Journal of Cell Science, 112(Pt 17), 2895-2901.
50. Smith, C. K., 2nd, Janney, M. J., & Allen, R. E. (1994). Temporal expression of myogenic regulatory genes during activation, proliferation, and differentiation of rat skeletal muscle satellite cells. Journal of Cellular Physiology, 159(2), 379-385.
51. Yablonka-Reuveni, Z., & Rivera, A. J. (1994). Temporal expression of regulatory and structural muscle proteins during myogenesis of satellite cells on isolated adult rat fibers. Developmental Biology, 164(2), 588-603.
52. Asakura, A., Komaki, M., & Rudnicki, M. (2001). Muscle satellite cells are multipotential stem cells that exhibit myogenic, osteogenic, and adipogenic differentiation. Differentiation, 68(4-5), 245-253.
53. Collins, C. A., & Partridge, T. A. (2005). Self-renewal of the adult skeletal muscle satellite cell. Cell Cycle, 4(10), 1338-1341.
54. Shefer, G., van de Mark, D. P., Richardson, J. B., & Yablonka-Reuveni, Z. (2006). Satellite-cell pool size does matter: defining the myogenic potency of aging skeletal muscle. Developmental Biology, 294(1), 50-66.
55. Halevy, O., Piestun, Y., Allouh, M. Z., et al. (2004). Pattern of Pax7 expression during myogenesis in the posthatch chicken establishes a model for satellite cell differentiation and renewal. Developmental Dynamics, 231(3), 489-502.
56. Hawke, T. J., & Garry, D. J. (2001). Myogenic satellite cells: physiology to molecular biology. Journal of Applied Physiology, 91(2), 534-551.
57. Turner, B. J., Lopes, E. C., & Cheema, S. S. (2003). Neuromuscular accumulation of mutant superoxide dismutase 1 aggregates in a transgenic mouse model of familial amyotrophic lateral sclerosis. Neuroscience Letters, 350(2), 132-136.
58. Hegedus, J., Putman, C. T., & Gordon, T. (2007). Time course of preferential motor unit loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. Neurobiology of Disease, 28(2), 154-164.
59. Pun, S., Santos, A. F., Saxena, S., Xu, L., & Caroni, P. (2006). Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nature Neuroscience, 9(3), 408-419.
60. Frey, D., Schneider, C., Xu, L., Borg, J., Spooren, W., & Caroni, P. (2000). Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. The Journal of Neuroscience, 20(7), 2534-2542.
61. Burkholder, T. J., Fingado, B., Baron, S., & Lieber, R. L. (1994). Relationship between muscle fiber types and sizes and muscle architectural properties in the mouse hindlimb. Journal of Morphology, 221(2), 177-190.
62. Day, K., Shefer, G., Richardson, J. B., Enikolopov, G., & Yablonka-Reuveni, Z. (2007). Nestin-GFP reporter expression defines the quiescent state of skeletal muscle satellite cells. Developmental Biology, 304(1), 246-259.
63. Day, K., Shefer, G., Shearer, A., & Yablonka-Reuveni, Z. The depletion of skeletal muscle satellite cells with age is concomitant with reduced capacity of single progenitors to produce reserve progeny. Developmental Biology, 340(2), 330-343.
64. Bradley, L. J., Taanman, J. W., Kallis, C., & Orrell, R. W. (2009). Increased sensitivity of myoblasts to oxidative stress in amyotrophic lateral sclerosis peripheral tissues. Experimental Neurology, 218(1), 92-97.
65. Manzano, R., Toivonen, J. M., Oliván, S., et al. (2011). Altered expression of myogenic regulatory factors in the mouse model of amyotrophic lateral sclerosis. Neurodegenerative Diseases. doi: 10. 1159/000324159.
66. Kuschel, R., Yablonka-Reuveni, Z., & Bornemann, A. (1999). Satellite cells on isolated myofibers from normal and denervated adult rat muscle. The Journal of Histochemistry and Cytochemistry, 47(11), 1375-1384.
67. Halter, B., Gonzalez de Aguilar, J. L., Rene, F., et al. Oxidative stress in skeletal muscle stimulates early expression of Rad in a mouse model of amyotrophic lateral sclerosis. Free Radical Biology & Medicine, 48(7): 915-923.